Clinical Trials
15 trialsNCT01107522 2025-09-09
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With TemodarĀ® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With TemodarĀ® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Tactical Therapeutics, Inc.
Phase 1 Unknown
NCT01672463 2023-03-29
OKN-007
Oblato, Inc.
Phase 1 Unknown
NCT05739500 2023-02-22
MRI-based Computer Aided Diagnosis Software (V1) for Glioma
Mingge LLC
Unknown
NCT03793088 2023-02-03
XCELSIOR
xCures
Unknown
NCT05540873 2023-01-06
A Clinical Study of IL13RĪ±2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)
CellabMED
Phase 1 Unknown
NCT00045968 2022-05-18
GBM
Northwest Biotherapeutics
Phase 3 Unknown
NCT05333588 2022-04-19
The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
Hebei Senlang Biotechnology Inc., Ltd.
Phase EARLY_PHASE1 Unknown
NCT02796261 2022-01-21
STELLAR
Orbus Therapeutics, Inc.
Phase 3 Unknown
NCT05063682 2021-10-01
CARTREMENDOUS
Chembrain LTD
Phase 1 Unknown
NCT04906473 2021-05-28
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
Kunming Pharmaceuticals, Inc.
Phase 1 Unknown
NCT03941626 2021-02-04
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
Shenzhen BinDeBio Ltd.
Phase 1/2 Unknown
NCT03638206 2019-12-11
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Phase 1/2 Unknown
NCT00591058 2009-07-17
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1 Unknown
NCT00683761 2009-07-17
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1/2 Unknown
NCT00114309 2009-04-03
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
TransMolecular
Phase 2 Unknown